Table 3.
Blood biochemistry parameters (mean ± SD) following 5-week repeated intravenous administration of AHT-102 in hCD3EDG mice on day 1 of the recovery period
| Parameters | Unit | Sex | Test date | Vehicle | AHT-102 (1.5 mg/kg) | AHT-102 (4.5 mg/kg) | AHT-102 (13.65 mg/kg) |
|---|---|---|---|---|---|---|---|
| ALB | g/L | Female | R1 | 36.3 ± 1.42 | 35.4 ± 1.15 | 34.1 ± 0.94** | 33.9 ± 1.23** |
| TP | g/L | Female | R1 | 42.8 ± 1.65 | 41.9 ± 1.36 | 40.2 ± 0.97** | 40.0 ± 1.95** |
| ALB | g/L | Male | R1 | 40.2 ± 1.45 | 38.1 ± 1.70 | 37.5 ± 3.07* | 37.9 ± 1.04* |
| A/G | Male | R1 | 3.85 ± 0.313 | 3.32 ± 0.241** | 3.64 ± 1.767* | 3.23 ± 0.226** |
R recovery phase, n = 10
A/G albumin/globulin ALB normal albumin, TP total protein
*Indicating statistical significance compared with vehicle control group of p < 0.05
**Indicating statistical significance compared with vehicle control group of p < 0.01